Fundraising Fox

Aethlon Medical

NASDAQ: AEMD

San Diego, US · Nevada corporation

Founders & leadership

RH
Richard H. TullisFounder
JB
James B. FrakesExecutive
RS
Rodney S. KenleyExecutive
JJ
James JoyceinPresident/CEOformer
RH
RICHARD H. TULLIS, PhDNamed on SEC filing

Board

CS
Chetan S. Shah, M.D.Board director
EG
Edward G. BroennimanBoard director
NG
Nicolas GikakisBoard director
AR
Angela RossettiBoard director
FS
Franklyn S. Barry, Jr.Board director
CS
CHETAN SHAH, MDBoard director

Reported raises · per SEC filings

Form D private placements

$20.2M disclosed across 10 rounds · 2011–2025

$2.2MraisedDec 2025 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chetan S. Shah, M.D.Director
  • James B. FrakesExecutive Officer, Director
  • Edward G. BroennimanDirector
  • Nicolas GikakisDirector
  • Angela RossettiDirector
Offering amount
$2.2M
Amount sold
$2.2M
Sales commissions
$214.5K
First sale
Dec 2025
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2.7MraisedJan 2020 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • TIMOTHY C. RODELLExecutive Officer, Director
  • SABRINA MARTUCCI JOHNSONDirector
  • EDWARD G. BROENNIMANDirector
  • CHARLES J. FISHERDirector
  • CHETAN S. SHAHDirector
  • JAMES B. FRAKESExecutive Officer
  • GUY CIPRIANIDirector
Offering amount
$2.7M
Amount sold
$2.7M
Sales commissions
$226.2K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$6MraisedJul 2015 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • RODNEY S. KENLEYExecutive Officer, Director
  • FRANKLYN S. BARRY, JR.Director
  • JAMES B. FRAKESExecutive Officer
  • EDWARD G. BROENNIMANDirector
  • RICHARD H. TULLIS, PhDExecutive Officer
  • JAMES A. JOYCEExecutive Officer, Director
  • CHETAN SHAH, MDDirector
Offering amount
$6M
Amount sold
$6M
Sales commissions
$360.5K
Placement agents
ROTH Capital Partners, LLC
First sale
Jun 2015
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$3.3MraisedDec 2014 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James B. FrakesExecutive Officer
  • Rodney S. KenleyExecutive Officer, Director
  • Franklyn S. Barry, Jr.Director
  • James A. JoyceExecutive Officer, Director
  • Edward G. BroennimanDirector
  • Richard H. Tullis, PhDExecutive Officer, Director
  • Chetan Shah, MDDirector
Offering amount
$3.3M
Amount sold
$3.3M
Sales commissions
$256K
Placement agents
ROTH Capital Partners, LLC
First sale
Dec 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$527.8KraisedNov 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rodney S. KenleyExecutive Officer, Director
  • Franklyn S. Barry, Jr.Director
  • Richard H. Tulls, PhDExecutive Officer, Director
  • James B. FrakesExecutive Officer
  • Chetan Shah, MDDirector
  • Edward G. BroennimanDirector
  • James A. JoyceExecutive Officer, Director
Offering amount
$527.8K
Amount sold
$527.8K
First sale
Nov 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$837.7KraisedNov 2014 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES A. JOYCEExecutive Officer, Director
  • RODNEY S. KENLEYExecutive Officer, Director
  • FRANKLYN S. BARRY, JR.Director
  • RICHARD H. TULLIS, PhDExecutive Officer, Director
  • CHETAN SHAH, MDDirector
  • JAMES B. FRAKESExecutive Officer
  • EDWARD G. BROENNIMANDirector
Offering amount
$837.7K
Amount sold
$837.7K
First sale
Oct 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$838.7KraisedNov 2014 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES B. FRAKESExecutive Officer
  • FRANKLYN S. BARRY, JR.Director
  • EDWARD G. BROENNIMANDirector
  • RICHARD H. TULLIS, PhDExecutive Officer, Director
  • JAMES A. JOYCEExecutive Officer, Director
  • RODNEY S. KENLEYExecutive Officer, Director
  • CHETAN SHAH, MDDirector
Offering amount
$838.7K
Amount sold
$838.7K
First sale
Jul 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$913.5KraisedNov 2014 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • EDWARD G. BROENNIMANDirector
  • RICHARD H. TULLIS, PhDExecutive Officer, Director
  • RODNEY S. KENLEYExecutive Officer, Director
  • CHETAN SHAH, MDDirector
  • JAMES A. JOYCEExecutive Officer, Director
  • FRANKLYN S. BARRY, JR.Director
  • JAMES B. FRAKESExecutive Officer
Offering amount
$913.5K
Amount sold
$913.5K
Minimum investment
$10K
First sale
May 2014
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Companies competing with Aethlon Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2019$1.9M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$298.4K
National Institutes of Health (NIH)National Institutes of HealthPhase I2017$299.3K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

Who founded Aethlon Medical?
Aethlon Medical was founded by Richard H. Tullis.
How much funding has Aethlon Medical raised?
Aethlon Medical has disclosed $20.2M raised across 10 rounds.
Where is Aethlon Medical headquartered?
Aethlon Medical is headquartered in San Diego, US.